Dishant Kalra

Head of Precision Medicine Astellas Pharma

Seminars

Tuesday 23rd September 2025
Panel Discussion: Advancing Partnerships to Ensure Compliant, Scalable Solutions for Global Precision Medicine Applications
3:30 pm
  • Determining a fit-for-purpose CDx strategy aligned with clinical trial endpoints
  • When should biomarker advancement trigger formal CDx development efforts for harmonized drug-diagnostic codevelopment?
  • How can collaborative, cross-functional teams streamline CDx integration into therapeutic development?
Thursday 25th September 2025
Biomarkers Commercialization: Diagnostics & Drug Development
11:30 am
  • Evaluating the role of commercial diagnostic strategy in supporting launch of companion diagnostics
  • Developing optimal strategies for test implementation and adoption at launch
  • Assessing the direct impact of suboptimal tests on patient outcomes
Dishant Kalra